{"DataElement":{"publicId":"65162","version":"3.1","preferredName":"Upper GI Tumor Histologic Classification Category","preferredDefinition":"the histologic type of an upper gastrointestinal tumor, including pancreas and esophagus.","longName":"UPPER_TUMOR_HIST_CAT","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2192254","version":"1","preferredName":"Upper GI Tumor Histologic Classification","preferredDefinition":"information related to upper GI tumor histologic classification or category.","longName":"UPPER_TUM_HIST_CLASS","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2206811","version":"1","preferredName":"Upper GI Neoplasm","preferredDefinition":"Upper Gastrointestinal Tract Radiography is an x-ray examination of the esophagus, stomach and first part of the small intestine following coating with barium solution via ingestion.:(NEE-o-PLAY-zha) Abnormal and uncontrolled cell growth.","longName":"C17639:C3262","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Upper Gastrointestinal Series","conceptCode":"C17639","definition":"An x-ray examination of the esophagus, stomach and first part of the small intestine following coating with barium solution via ingestion.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Neoplasm","conceptCode":"C3262","definition":"A benign or malignant tissue growth resulting from uncontrolled cell proliferation. Benign neoplastic cells resemble normal cells without exhibiting significant cytologic atypia, while malignant cells exhibit overt signs such as dysplastic features, atypical mitotic figures, necrosis, nuclear pleomorphism, and anaplasia. Representative examples of benign neoplasms include papillomas, cystadenomas, and lipomas; malignant neoplasms include carcinomas, sarcomas, lymphomas, and leukemias.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-0575-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2207691","version":"1","preferredName":"Histologic Classification","preferredDefinition":"Of or relating to histology.:Classification; the grouping of things into classes or categories.","longName":"C25526:C25161","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Classification","conceptCode":"C25161","definition":"A method of generalization, the systematic arrangement of entities into classes or groups based on mutual similarity and certain differing characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-2C90-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E9049DF1-1AEF-68A8-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-16","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-11-16","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2018428","version":"2","preferredName":"Upper GI Tumor Histologic Category","preferredDefinition":"the histologic type of an upper gastrointestinal tumor, including pancreas and esophagus.","longName":"UPPER_TUMOR_HIST_CAT","context":"CTEP","contextVersion":"2.31","type":"Enumerated","dataType":"CHARACTER","minLength":"5","maxLength":"50","minValue":null,"maxValue":null,"decimalPlace":null,"PermissibleValues":[{"value":"Intraductal papillary mucinous neoplasm with invasive adenocarcinoma","valueDescription":"Intraductal papillary mucinous neoplasm with invasive adenocarcinoma","ValueMeaning":{"publicId":"2875650","version":"1","preferredName":"Intraductal papillary mucinous neoplasm with invasive adenocarcinoma","longName":"2875650","preferredDefinition":"Intraductal papillary mucinous neoplasm with invasive adenocarcinoma","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"69BD0C4D-F003-3BE7-E040-BB89AD431A9B","latestVersionIndicator":"Yes","beginDate":"2009-05-12","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-12","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A163-179B-E040-BB89AD434281","beginDate":"2009-05-12","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Acinar cell carcinoma","valueDescription":"Acinar Cell Carcinoma","ValueMeaning":{"publicId":"2558157","version":"1","preferredName":"Acinar Cell Carcinoma","longName":"2558157","preferredDefinition":"A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. Representative examples include the acinar cell carcinoma of the pancreas and the acinar adenocarcinoma of the prostate gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Acinar Cell Carcinoma","conceptCode":"C3768","definition":"A malignant glandular epithelial neoplasm consisting of secretory cells forming acinar patterns. Representative examples include the acinar cell carcinoma of the pancreas and the acinar adenocarcinoma of the prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B03A-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A16D-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Adenocarcinoma","valueDescription":"Adenocarcinoma","ValueMeaning":{"publicId":"2567203","version":"1","preferredName":"Adenocarcinoma","longName":"2567203","preferredDefinition":"A common cancer characterized by the presence of malignant glandular cells. Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous). Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenocarcinoma","conceptCode":"C2852","definition":"A common cancer characterized by the presence of malignant glandular cells.  Morphologically, adenocarcinomas are classified according to the growth pattern (e.g., papillary, alveolar) or according to the secreting product (e.g., mucinous, serous).  Representative examples of adenocarcinoma are ductal and lobular breast carcinoma, lung adenocarcinoma, renal cell carcinoma, hepatocellular carcinoma (hepatoma), colon adenocarcinoma, and prostate adenocarcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D390-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A177-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Adenosquamous carcinoma","valueDescription":"ADENOSQUAMOUS CARCINOMA","ValueMeaning":{"publicId":"2558186","version":"1","preferredName":"ADENOSQUAMOUS CARCINOMA","longName":"2558186v1.00","preferredDefinition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Adenosquamous Carcinoma","conceptCode":"C3727","definition":"An invasive carcinoma composed of malignant glandular cells and malignant squamous cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B057-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A181-179B-E040-BB89AD434281","beginDate":"2002-08-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Ductal adenocarcinoma","valueDescription":"DUCTAL ADENOCARCINOMA","ValueMeaning":{"publicId":"2558692","version":"1","preferredName":"DUCTAL ADENOCARCINOMA","longName":"2558692","preferredDefinition":"DUCTAL ADENOCARCINOMA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B251-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A18B-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Mixed-type (ductal-endocrine or acinar-endocrine)","valueDescription":"MIXED-TYPE (DUCTAL-ENDOCRINE OR ACINAR-ENDOCRINE)","ValueMeaning":{"publicId":"2559258","version":"1","preferredName":"MIXED-TYPE (DUCTAL-ENDOCRINE OR ACINAR-ENDOCRINE)","longName":"2559258","preferredDefinition":"MIXED-TYPE (DUCTAL-ENDOCRINE OR ACINAR-ENDOCRINE)","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B487-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A195-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Mucinous adenocarcinoma","valueDescription":"Mucinous adenocarcinoma","ValueMeaning":{"publicId":"2567179","version":"1","preferredName":"Mucinous adenocarcinoma","longName":"2567179","preferredDefinition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Mucinous Adenocarcinoma","conceptCode":"C26712","definition":"An invasive adenocarcinoma composed of malignant glandular cells which contain intracytoplasmic mucin. Often, the infiltrating glandular structures are associated with mucoid stromal formation. It may arise from the large and small intestine, appendix, stomach, lung, ovary, breast, corpus uteri, cervix, vagina, and salivary gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D378-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2013-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A19F-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Mucinous noncystic carcinoma","valueDescription":"MUCINOUS NONCYSTIC CARCINOMA","ValueMeaning":{"publicId":"2559286","version":"1","preferredName":"MUCINOUS NONCYSTIC CARCINOMA","longName":"2559286","preferredDefinition":"MUCINOUS NONCYSTIC CARCINOMA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B4A3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A1A9-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Neuroendocrine carcinoma","valueDescription":"Neuroendocrine Carcinoma","ValueMeaning":{"publicId":"2559503","version":"1","preferredName":"Neuroendocrine Carcinoma","longName":"2559503","preferredDefinition":"A malignant neuroendocrine tumor composed of cells containing secretory granules that stain positive for NSE and chromogranin.  Tumor cells are often round and form clusters or trabecular sheets.  Representative examples are carcinoid tumor, small cell carcinoma, and Merkel cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Neuroendocrine Carcinoma","conceptCode":"C3773","definition":"A usually aggressive carcinoma composed of malignant cells exhibiting neuroendocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B57C-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"CURTIST","dateModified":"2011-04-13","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A1B3-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Signet ring cell carcinoma","valueDescription":"SIGNET RING CELL CARCINOMA","ValueMeaning":{"publicId":"2560049","version":"1","preferredName":"SIGNET RING CELL CARCINOMA","longName":"2560049v1.00","preferredDefinition":"A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Signet Ring Cell Carcinoma","conceptCode":"C3774","definition":"A usually aggressive, poorly differentiated invasive adenocarcinoma characterized by the presence of malignant glandular cells in which the nucleus is pressed to one side by the presence of intracytoplasmic mucus. It may arise from the stomach, small and large intestine, ampulla of Vater, appendix, gallbladder, pancreas, lung, bladder, breast, and prostate gland.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B79E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A1BD-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Small cell carcinoma","valueDescription":"Small cell carcinoma","ValueMeaning":{"publicId":"2567204","version":"1","preferredName":"Small cell carcinoma","longName":"2567204","preferredDefinition":"A neuroendocrine carcinoma composed of small malignant cells which are often said to resemble \"oat cells\" under the microscope.  Small cell carcinoma most often affects the lungs.  Clinically, this is often a rapidly growing cancer that spreads to distant sites early.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Small Cell Neuroendocrine Carcinoma","conceptCode":"C3915","definition":"An aggressive, high-grade, and poorly differentiated carcinoma with neuroendocrine differentiation. It is composed of malignant small cells.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D391-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A1C7-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Squamous cell carcinoma","valueDescription":"Squamous cell carcinoma","ValueMeaning":{"publicId":"2574081","version":"1","preferredName":"Squamous cell carcinoma","longName":"2574081","preferredDefinition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Squamous Cell Carcinoma","conceptCode":"C2929","definition":"A carcinoma arising from squamous epithelial cells.  Morphologically, it is characterized by the proliferation of atypical, often pleomorphic squamous cells.  Squamous cell carcinomas are graded by the degree of cellular differentiation as well, moderately, or poorly differentiated.  Well differentiated carcinomas are usually associated with keratin production and the presence of intercellular bridges between adjacent cells.  Representative examples are lung squamous cell carcinoma, skin squamous cell carcinoma, and cervical squamous cell carcinoma.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-EE6E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-11-14","endDate":null,"createdBy":"SBREXT","dateCreated":"2003-11-14","modifiedBy":"REEVESD","dateModified":"2016-04-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A1D1-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Tubular adenocarcinoma","valueDescription":"Tubular Adenocarcinoma","ValueMeaning":{"publicId":"2560320","version":"1","preferredName":"Tubular Adenocarcinoma","longName":"2560320","preferredDefinition":"An aggressive adenocarcinoma that arises from the sweat glands. It usually presents as a firm, erythematous nodular lesion in the axilla. Morphologically, it is characterized by the presence of tubular structures and apocrine differentiation.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Sweat Gland Tubular Carcinoma","conceptCode":"C3682","definition":"An aggressive adenocarcinoma that arises from the sweat glands. It usually presents as a firm, erythematous nodular lesion in the axilla. Morphologically, it is characterized by the presence of tubular structures and apocrine differentiation.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8AD-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"REEVESD","dateModified":"2013-10-09","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A1DB-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Undifferentiated (anaplastic) carcinoma","valueDescription":"UNDIFFERENTIATED (ANAPLASTIC) CARCINOMA","ValueMeaning":{"publicId":"2560390","version":"1","preferredName":"UNDIFFERENTIATED (ANAPLASTIC) CARCINOMA","longName":"2560390","preferredDefinition":"UNDIFFERENTIATED (ANAPLASTIC) CARCINOMA","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8F3-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A1E5-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Undifferentiated carcinoma with osteoclast-like giant cells","valueDescription":"UNDIFFERENTIATED CARCINOMA WITH OSTEOCLAST-LIKE GIANT CELLS","ValueMeaning":{"publicId":"2560393","version":"1","preferredName":"UNDIFFERENTIATED CARCINOMA WITH OSTEOCLAST-LIKE GIANT CELLS","longName":"2560393","preferredDefinition":"UNDIFFERENTIATED CARCINOMA WITH OSTEOCLAST-LIKE GIANT CELLS","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B8F6-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A1EF-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Other","valueDescription":"OTHER SPECIFY","ValueMeaning":{"publicId":"2559668","version":"1","preferredName":"OTHER SPECIFY","longName":"2559668","preferredDefinition":"Be specific about something; define clearly.: Different than the one(s) previously specified or mentioned.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Specify","conceptCode":"C25685","definition":"Be specific about something; define clearly.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Other","conceptCode":"C17649","definition":"Different than the one(s) previously specified or mentioned.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-B621-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2002-02-13","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"SOKKERL","dateModified":"2018-05-11","changeDescription":"Concept annotation added for UPitt/TCGA.  Ylu, 01/29/2015.","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A1F9-179B-E040-BB89AD434281","beginDate":"2002-02-11","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Mixed Ductal-Endocrine Carcinoma","valueDescription":"Mixed Ductal-Endocrine Carcinoma","ValueMeaning":{"publicId":"2574561","version":"1","preferredName":"Mixed Ductal-Endocrine Carcinoma","longName":"2574561v1.00","preferredDefinition":"A carcinoma that arises from the pancreas showing a mixture of ductal and neuroendocrine malignant cells in both the primary tumor and in the metastatic sites.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Pancreatic Mixed Ductal-Neuroendocrine Carcinoma","conceptCode":"C6879","definition":"A carcinoma that arises from the pancreas showing a mixture of ductal and neuroendocrine malignant cells in both the primary tumor and in the metastatic sites.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-F04E-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-04-22","modifiedBy":"KUMMEROA","dateModified":"2023-08-24","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6AFD1B6C-A203-179B-E040-BB89AD434281","beginDate":"2005-04-22","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"ONEDATA","dateModified":"2009-05-28","deletedIndicator":"No"},{"value":"Mucinous cystadenocarcinoma","valueDescription":"Mucinous cystadenocarcinoma - invasive","ValueMeaning":{"publicId":"2897787","version":"1","preferredName":"Mucinous cystadenocarcinoma - invasive","longName":"2897787","preferredDefinition":"Mucinous cystadenocarcinoma - invasive","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B943018-A51A-1429-E040-BB89AD4312C2","latestVersionIndicator":"Yes","beginDate":"2009-06-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-06-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6B943018-A533-1429-E040-BB89AD4312C2","beginDate":"2009-06-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-06-05","modifiedBy":"ONEDATA","dateModified":"2009-06-05","deletedIndicator":"No"},{"value":"Serous cystadenocarcinoma","valueDescription":"Serous Cystadenocarcinoma","ValueMeaning":{"publicId":"2581792","version":"1","preferredName":"Serous Cystadenocarcinoma","longName":"2581792","preferredDefinition":"A malignant cystic or semicystic neoplasm. It often occurs in the ovary and usually bilaterally. The external surface is usually covered with papillary excrescences. Microscopically, the papillary patterns are predominantly epithelial overgrowths with differentiated and undifferentiated papillary serous cystadenocarcinoma cells. Psammoma bodies may be present. The tumor generally adheres to surrounding structures and produces ascites. (From Hughes, Obstetric-Gynecologic Terminology, 1972, p185)","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Serous Cystadenocarcinoma","conceptCode":"C3778","definition":"A malignant serous cystic neoplasm usually involving the ovary or the pancreas. It is characterized by the presence of invasive malignant glandular epithelial cells which often form papillary structures.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE88-0C8D-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-10","endDate":null,"createdBy":"SCHMANDL","dateCreated":"2006-11-10","modifiedBy":"ONEDATA","dateModified":"2006-11-10","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6B943018-A547-1429-E040-BB89AD4312C2","beginDate":"2009-06-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-06-05","modifiedBy":"ONEDATA","dateModified":"2009-06-05","deletedIndicator":"No"},{"value":"Intraductal papillary mucinous neoplasm","valueDescription":"Intraductal papillary mucinous neoplasm","ValueMeaning":{"publicId":"2897788","version":"1","preferredName":"Intraductal papillary mucinous neoplasm","longName":"2897788","preferredDefinition":"Intraductal papillary mucinous neoplasm","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6B943018-A552-1429-E040-BB89AD4312C2","latestVersionIndicator":"Yes","beginDate":"2009-06-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-06-05","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"6B943018-A56B-1429-E040-BB89AD4312C2","beginDate":"2009-06-05","endDate":null,"createdBy":"ALAIS","dateCreated":"2009-06-05","modifiedBy":"ONEDATA","dateModified":"2009-06-05","deletedIndicator":"No"},{"value":"Unknown","valueDescription":"Unknown","ValueMeaning":{"publicId":"2960664","version":"1","preferredName":"Unknown","longName":"2960664","preferredDefinition":"Not known, not observed, not recorded, or refused.","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Unknown","conceptCode":"C17998","definition":"Not known, observed, recorded; or reported as unknown by the data contributor.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"78485FBD-4C65-D67B-E040-BB89AD432E0E","latestVersionIndicator":"Yes","beginDate":"2009-11-13","endDate":null,"createdBy":"AHMEDS","dateCreated":"2009-11-13","modifiedBy":"KUMMEROA","dateModified":"2023-12-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF6D3778-2D25-5529-E040-BB89AD43092C","beginDate":"2014-07-30","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-30","modifiedBy":"ONEDATA","dateModified":"2014-07-30","deletedIndicator":"No"},{"value":"Mucin-producing","valueDescription":"Mucin-producing","ValueMeaning":{"publicId":"4419655","version":"1","preferredName":"Mucin-producing","longName":"4419655","preferredDefinition":"Mucin-producing","context":"NCIP","contextVersion":"1","Concepts":[],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"FF6D3778-2D2F-5529-E040-BB89AD43092C","latestVersionIndicator":"Yes","beginDate":"2014-07-30","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-30","modifiedBy":"SBR","dateModified":"2018-01-19","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF6D3778-2D48-5529-E040-BB89AD43092C","beginDate":"2014-07-30","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-30","modifiedBy":"ONEDATA","dateModified":"2014-07-30","deletedIndicator":"No"},{"value":"Undifferentiated","valueDescription":"Undifferentiated Histology","ValueMeaning":{"publicId":"2560389","version":"1","preferredName":"Undifferentiated Histology","longName":"2560389v1.00","preferredDefinition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively._The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","context":"PMI","contextVersion":"1","Concepts":[{"longName":"Undifferentiated","conceptCode":"C14176","definition":"Describes tumor cells that generally have lost all of the appearance of normal cells. They tend to grow and spread quickly and aggressively.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Histology","conceptCode":"C16681","definition":"The study of the structure of the cells and their arrangement to constitute tissues and, finally, the association among these to form organs.  In pathology, the microscopic process of identifying normal and abnormal morphologic characteristics in tissues, by employing various cytochemical and immunocytochemical stains.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"DRAFT NEW","registrationStatus":"Application","id":"2509CE87-B8F2-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2022-08-05","endDate":null,"createdBy":"SBR","dateCreated":"2002-02-13","modifiedBy":"MMADDINENI","dateModified":"2023-07-26","changeDescription":null,"administrativeNotes":"8/5/2022: created for PMI EC form. SL","unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF6D3778-2D52-5529-E040-BB89AD43092C","beginDate":"2014-07-30","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-30","modifiedBy":"ONEDATA","dateModified":"2014-07-30","deletedIndicator":"No"},{"value":"Carcinosarcoma","valueDescription":"CARCINOSARCOMA","ValueMeaning":{"publicId":"2566465","version":"1","preferredName":"CARCINOSARCOMA","longName":"2566465","preferredDefinition":"CARCINOSARCOMA","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Carcinosarcoma","conceptCode":"C34448","definition":"A malignant tumor composed of a mixture of carcinomatous and sarcomatous elements.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"2509CE87-D0AE-5C23-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2003-08-11","endDate":null,"createdBy":"PWEST","dateCreated":"2003-08-11","modifiedBy":"SBREXT","dateModified":"2007-11-07","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"id":"FF6D3778-2D5C-5529-E040-BB89AD43092C","beginDate":"2014-07-30","endDate":null,"createdBy":"ROUILLAS","dateCreated":"2014-07-30","modifiedBy":"ONEDATA","dateModified":"2014-07-30","deletedIndicator":"No"}],"ConceptualDomain":{"publicId":"2008537","version":"1","preferredName":"Diagnosis","preferredDefinition":"the process of identifying a disease by the signs and symptoms (NCI Glossary).","longName":"DX","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B205508C-8324-69B0-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-17","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-17","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2208105","version":"1","preferredName":"Histologic Category","preferredDefinition":"Of or relating to histology.:Category; used informally to mean a class of things.","longName":"C25526:C25372","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Histologic","conceptCode":"C25526","definition":"Pertaining to the combined microscopic physical features of cells and their surrounding extracellular environment in tissues.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Category","conceptCode":"C25372","definition":"A grouping of items based on some commonality or by user defined characteristics.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"F37D0429-3D9A-6787-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-03-29","endDate":null,"createdBy":"SBR","dateCreated":"2005-03-29","modifiedBy":"ONEDATA","dateModified":"2005-03-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"6AFD1B6C-A14C-179B-E040-BB89AD434281","latestVersionIndicator":"Yes","beginDate":"2005-04-22","endDate":"2009-05-28","createdBy":"ALAIS","dateCreated":"2009-05-28","modifiedBy":"SOKKERL","dateModified":"2018-05-11","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811911","version":"1","longName":"Upper GI","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811963","version":"1","longName":"Treatment","context":"CTEP"}]},{"publicId":"2008594","version":"2.31","longName":"Trial Type Usages (CDE Disease Committees)","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811789","version":"1","longName":"Adjuvant Esophageal","context":"CTEP"},{"publicId":"2811790","version":"1","longName":"Adjuvant Gastric","context":"CTEP"},{"publicId":"2811792","version":"1","longName":"Advanced Esophageal","context":"CTEP"},{"publicId":"10000446","version":"1","longName":"Advanced Gastric","context":"CTEP"},{"publicId":"2811827","version":"1","longName":"Unresect Pancreatic","context":"CTEP"},{"publicId":"2811829","version":"1","longName":"Resect Pancreatic","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"4171060","version":"1","longName":"RTOG-0848","context":"NRG"}]}],"AlternateNames":[{"name":"UPPER_TUMOR_HIST_CAT","type":"USED_BY","context":"NRG"},{"name":"ECOG-ACRIN","type":"USED_BY","context":"ECOG-ACRIN"}],"ReferenceDocuments":[{"name":"CRF Text","type":"Alternate Question Text","description":"Histology","url":null,"context":"CTEP"},{"name":"Histologic Type","type":"Preferred Question Text","description":"Histologic Type","url":null,"context":"CTEP"}],"origin":"Upper Gastrointestinal CDE Disease Committee","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"F5595295-B2C2-42AF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2005-04-22","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2005-04-22","modifiedBy":"ROUILLAS","dateModified":"2015-01-08","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}